Matches in Wikidata for { <http://www.wikidata.org/entity/Q57021652> ?p ?o ?g. }
- Q57021652 description "article scientifique publié en 2018" @default.
- Q57021652 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57021652 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57021652 description "scientific article published on 05 October 2018" @default.
- Q57021652 description "wetenschappelijk artikel" @default.
- Q57021652 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57021652 name "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 name "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 type Item @default.
- Q57021652 label "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 label "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 prefLabel "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 prefLabel "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I" @default.
- Q57021652 P1433 Q57021652-30CF32F3-8372-4926-A6CE-2BFA706B19ED @default.
- Q57021652 P1476 Q57021652-60269BA4-BDE2-4CD1-A30B-00F01D51E625 @default.
- Q57021652 P2093 Q57021652-0014B1C6-83DC-493C-9D7F-DFE7F97CAFFE @default.
- Q57021652 P2093 Q57021652-1C12ED1A-1DA1-4931-9999-A5EFD788D4A5 @default.
- Q57021652 P2093 Q57021652-50D6F8CE-686E-4D46-A8CB-AB4E7510F9D4 @default.
- Q57021652 P2093 Q57021652-53D111CA-BE34-4E4C-8EEE-886E975E0EA4 @default.
- Q57021652 P2093 Q57021652-634F9B4B-8ADF-40DF-BEBD-FA6E54A937ED @default.
- Q57021652 P2093 Q57021652-B008B3B4-E6E5-4801-9D00-9A48190936F5 @default.
- Q57021652 P2093 Q57021652-D1C0EEFA-6F92-458B-9EC1-83C648CDB603 @default.
- Q57021652 P2093 Q57021652-E596CC51-3F53-4494-B03F-7AC2B70BD190 @default.
- Q57021652 P2860 Q57021652-01CB640E-2454-46D9-85FC-C15D78C23F8C @default.
- Q57021652 P2860 Q57021652-06352A95-A505-49C0-8C4A-2B13EC4F9443 @default.
- Q57021652 P2860 Q57021652-0AAA1E1F-24C3-4BC6-9E22-66DFF220556C @default.
- Q57021652 P2860 Q57021652-0AFB3CCC-2BEE-4D17-BBEE-0FE4E8D484E4 @default.
- Q57021652 P2860 Q57021652-0C3229D2-5370-490D-98ED-08726429F5EA @default.
- Q57021652 P2860 Q57021652-1A883D48-1CA1-41FE-A044-4F49BB47C1C5 @default.
- Q57021652 P2860 Q57021652-2C713469-E714-4A48-B983-2B597A2DDC4E @default.
- Q57021652 P2860 Q57021652-2CB048F5-41D9-465E-9F28-DF5482F8D042 @default.
- Q57021652 P2860 Q57021652-3019B296-2E69-40DB-9B37-189263A0520C @default.
- Q57021652 P2860 Q57021652-539160C5-FDB9-4534-BBCD-273B9230535C @default.
- Q57021652 P2860 Q57021652-5D45A70C-247C-487A-98CD-DB020F3E8C14 @default.
- Q57021652 P2860 Q57021652-5FB7B5F7-AA9B-47C1-BB9C-03009E02DD77 @default.
- Q57021652 P2860 Q57021652-636A382E-7238-4845-A4DA-45E124F6929C @default.
- Q57021652 P2860 Q57021652-65671A7E-0037-4E87-971E-6A0A56713E59 @default.
- Q57021652 P2860 Q57021652-720FF0A9-EC45-4F1C-BFDC-EB028A946824 @default.
- Q57021652 P2860 Q57021652-9658F467-C653-4866-8476-2F338D25C2DF @default.
- Q57021652 P2860 Q57021652-99583627-64BB-4600-B943-0EB4A95CE7D5 @default.
- Q57021652 P2860 Q57021652-9C9A7FA0-0D1F-4B8D-AC9B-4FF5CE3BC5BE @default.
- Q57021652 P2860 Q57021652-AB70CD10-5B9F-4F5D-9CF6-7423EE07AADC @default.
- Q57021652 P2860 Q57021652-B494C1D8-0479-4F15-BF80-B8DE40A5F523 @default.
- Q57021652 P2860 Q57021652-BB31DEFB-E660-48BF-B40E-47B050BEA7C3 @default.
- Q57021652 P2860 Q57021652-C50822A0-9AB7-4C56-8AC3-FC3FCC0042F7 @default.
- Q57021652 P2860 Q57021652-DD68A84F-C05B-450E-82C3-619D99944462 @default.
- Q57021652 P2860 Q57021652-E0C065AF-73A8-4316-AC88-9702FDBA7773 @default.
- Q57021652 P2860 Q57021652-F8D51FFF-7A7F-4993-8644-ED7D210750C6 @default.
- Q57021652 P304 Q57021652-326AC5FE-D401-493B-BE38-5B72099CB9B4 @default.
- Q57021652 P31 Q57021652-253F8A0A-2B72-4BC5-AB45-AEFCE2FC531F @default.
- Q57021652 P356 Q57021652-13C68FAB-1DDA-4344-AE43-E5C6F1D72607 @default.
- Q57021652 P407 Q57021652-2582F45D-8FC3-4A33-9790-32035EAD95FB @default.
- Q57021652 P433 Q57021652-7E730922-B521-4C2C-8733-07FA617693B1 @default.
- Q57021652 P478 Q57021652-4F6954EE-086F-471F-9512-291B3314F54D @default.
- Q57021652 P50 Q57021652-98D745C1-9055-49EB-9373-2E074FD4207A @default.
- Q57021652 P577 Q57021652-5553A3E1-FDE7-440E-82E2-A34693624669 @default.
- Q57021652 P698 Q57021652-EBD97A15-49B0-4C03-A1B7-1C8E74DA12C2 @default.
- Q57021652 P921 Q57021652-1300595C-068F-4258-856D-937428BA892E @default.
- Q57021652 P921 Q57021652-3785CF33-1B67-449D-A95A-B0CE5864C0F4 @default.
- Q57021652 P921 Q57021652-6697BFEC-573B-4F71-A644-7D80F4A7770E @default.
- Q57021652 P921 Q57021652-6AD916CB-AAFD-40E0-B424-F121A6A5DD4A @default.
- Q57021652 P921 Q57021652-84E951D3-08D0-49F3-AE6A-502024D6278C @default.
- Q57021652 P921 Q57021652-D1AED7B7-D2AB-4287-BC07-83DAADA67857 @default.
- Q57021652 P921 Q57021652-E43269A7-D189-484B-BBAC-72B09E07A47D @default.
- Q57021652 P356 S00228-018-2566-6 @default.
- Q57021652 P698 30291369 @default.
- Q57021652 P1433 Q1376707 @default.
- Q57021652 P1476 "Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials" @default.
- Q57021652 P2093 "Amit Khatri" @default.
- Q57021652 P2093 "Bifeng Ding" @default.
- Q57021652 P2093 "Daniel E Cohen" @default.
- Q57021652 P2093 "Diana L Shuster" @default.
- Q57021652 P2093 "Eric Cohen" @default.
- Q57021652 P2093 "Hong Li" @default.
- Q57021652 P2093 "Melissa Jewett" @default.
- Q57021652 P2093 "Rajeev M Menon" @default.
- Q57021652 P2860 Q31168457 @default.
- Q57021652 P2860 Q33647694 @default.
- Q57021652 P2860 Q34469287 @default.
- Q57021652 P2860 Q34580579 @default.
- Q57021652 P2860 Q34966853 @default.
- Q57021652 P2860 Q34980383 @default.
- Q57021652 P2860 Q35528192 @default.
- Q57021652 P2860 Q36333772 @default.
- Q57021652 P2860 Q37187535 @default.
- Q57021652 P2860 Q38032025 @default.
- Q57021652 P2860 Q38551250 @default.
- Q57021652 P2860 Q39778146 @default.
- Q57021652 P2860 Q39920614 @default.
- Q57021652 P2860 Q40057348 @default.
- Q57021652 P2860 Q40209829 @default.
- Q57021652 P2860 Q40621621 @default.
- Q57021652 P2860 Q40674752 @default.
- Q57021652 P2860 Q40674760 @default.
- Q57021652 P2860 Q40674767 @default.
- Q57021652 P2860 Q40697687 @default.
- Q57021652 P2860 Q40947776 @default.
- Q57021652 P2860 Q41358146 @default.
- Q57021652 P2860 Q41506667 @default.
- Q57021652 P2860 Q41924793 @default.